Literature DB >> 25108762

Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.

G Ravi1, Yeldur P Venkatesh.   

Abstract

D-Ribitol-5-phosphate (Rbt-5-P) is an important metabolite in the pentose phosphate pathway and an integral part of bacterial cell wall polysaccharides, specifically as polyribosyl ribitol phosphate (PRP) in Haemophilus influenzae type b (Hib). The major objective of this study was to investigate whether an antibody specific to Rbt-5-P can recognize the PRP of Hib. D-Ribose-5-phosphate was reacted with proteins in the presence of sodium cyanoborohydride to obtain Rbt-5-P epitopes; 120 h reaction resulted in conjugation of ~30 and ~17 moles of Rbt-5-P/mole of BSA and OVA, respectively, based on decrease in amino groups, MALDI-TOF analyses, an increase in apparent molecular weight (SDS-PAGE) and glycoprotein staining. Immunization of rabbits with Rbt-5-P-BSA conjugate generated antibodies to Rbt-5-P as demonstrated by dot immunoblot and non-competitive ELISA. Homogeneous Rbt-5-P-specific antibody was purified from Rbt-5-P-BSA antiserum subjected to caprylic acid precipitation followed by hapten-affinity chromatography; its affinity constant is 7.1 × 10(8) M(-1). Rbt-5-P antibody showed 100 % specificity to Rbt-5-P, ~230 %, 10 % and 3.4 % cross-reactivity to FMN, riboflavin and FAD, respectively; the antibody showed ~4 % cross-reactivity to D-ribitol and <3 % to other sugars/sugar alcohols. Rbt-5-P-specific antibody recognized Hib conjugate vaccines containing PRP which was inhibited specifically by Rbt-5-P, and also detected Hib cell-surface capsular polysaccharides by immunofluorescence. In conclusion, Rbt-5-P-protein conjugate used as an immunogen elicited antibodies binding to an epitope also present in PRP and Hib bacteria. Rbt-5-P-specific antibody has potential applications in the detection and quantification of free/bound Rbt-5-P and FMN as well as immunological recognition of Hib bacteria and its capsular polysaccharide.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25108762     DOI: 10.1007/s10719-014-9539-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  42 in total

1.  Frontal gel chromatographic analysis of the interaction of a protein with self-associating ligands: aberrant saturation in the binding of flavins to bovine serum albumin.

Authors:  O Sawada; T Ishida; K Horiike
Journal:  J Biochem       Date:  2001-06       Impact factor: 3.387

2.  Immobilization of proteins on oxidized crosslinked Sepharose preparations by reductive amination.

Authors:  N L Stults; L M Asta; Y C Lee
Journal:  Anal Biochem       Date:  1989-07       Impact factor: 3.365

Review 3.  Protein identification by mass spectrometry: issues to be considered.

Authors:  Michael A Baldwin
Journal:  Mol Cell Proteomics       Date:  2003-11-06       Impact factor: 5.911

4.  Comparative study of flavins binding with human serum albumin: a fluorometric, thermodynamic, and molecular dynamics approach.

Authors:  Abhigyan Sengupta; Wilbee D Sasikala; Arnab Mukherjee; Partha Hazra
Journal:  Chemphyschem       Date:  2012-04-24       Impact factor: 3.102

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The dot immunobinding assay.

Authors:  R Hawkes
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

8.  Method for determining the affinity of monoclonal antibody using non-competitive ELISA: a computer program.

Authors:  G P Raghava; J N Agrewala
Journal:  J Immunoassay       Date:  1994-05

9.  Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism.

Authors:  Mirjam M C Wamelink; Eduard A Struys; Jojanneke H J Huck; Birthe Roos; Marjo S van der Knaap; Cornelis Jakobs; Nanda M Verhoeven
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-01-23       Impact factor: 3.205

10.  Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.

Authors:  V Fernández-Santana; Félix Cardoso; Arlene Rodriguez; Tania Carmenate; Luis Peña; Yuri Valdés; Eugenio Hardy; Fatme Mawas; Lazaro Heynngnezz; Maria C Rodríguez; Ignacio Figueroa; Janoi Chang; Maria E Toledo; Alexis Musacchio; Ibis Hernández; Mabel Izquierdo; Karelia Cosme; Rene Roy; V Verez-Bencomo
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

View more
  1 in total

Review 1.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.